SEREXIS™ 180 Sample Kit, Defined FBS Replacement for Multiple Cell Types, with Lipid Mix 180

Description

SEREXIS™ 180 Sample Kit is designed for the initial evaluation of SEREXIS™ 180 as a defined replacement for fetal bovine serum (FBS) in cell culture. It contains SEREXIS™ 180 and Lipid Mix 180, enabling users to assess FBS-like performance with the flexibility to include additional lipid supplementation when required.

SEREXIS™ 180 is designed for direct substitution at standard serum concentrations and can be integrated into established FBS-based workflows without major protocol changes. It supports reliable cell growth, adherence, proliferation, viability, and morphology across multiple cell types, including A549, HeLa, MDCK, Vero, primary immune cells, keratinocytes, and fibroblasts.

With its defined and homogeneous formulation, SEREXIS™ 180 enables a decisive step beyond conventional serum supplementation: high cell culture performance, without relying on FBS.

The included Lipid Mix 180 provides additional flexibility for demanding cell systems with increased lipid or fatty acid requirements, while SEREXIS™ 180 remains suitable as a standalone FBS replacement for most applications.

Key Benefits

• Flexible sample kit for initial SEREXIS™ 180 evaluation including Lipid Mix 180
• High performance without FBS for robust growth and stable morphology
• Defined formulation for improved reproducibility and control
• Direct switch from FBS at standard serum concentrations
• Broadly validated across cell lines and primary cells
• Workflow-friendly integration without major protocol changes
• Optional Lipid Mix 180 for cell types with increased lipid or fatty acid requirements
• Controlled sourcing and enhanced viral safety for sensitive applications

The SEREXIS™ product line includes three grades designed for different application requirements: 

• SEREXIS™ 180 for general cell culture workflows
• SEREXIS™ 190 Qualified for diagnostic applications and sensitive laboratory workflows requiring enhanced traceability and documentation
• SEREXIS™ 200 Biopharma Grade for vaccine manufacturing, biotech production, and highly regulated biopharma workflows requiring the highest level of documentation, regulatory compliance and viral safety support